ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $160,000 | +122.2% | 441 | 0.0% | 0.00% | +100.0% |
| Q2 2015 | $72,000 | -24.2% | 441 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $95,000 | -60.3% | 441 | -53.7% | 0.00% | -60.0% |
| Q4 2014 | $239,000 | +1393.8% | 952 | +1730.8% | 0.01% | – |
| Q3 2014 | $16,000 | -42.9% | 52 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $28,000 | +27.3% | 52 | 0.0% | 0.00% | – |
| Q1 2014 | $22,000 | -69.9% | 52 | -95.8% | 0.00% | -100.0% |
| Q4 2013 | $73,000 | -37.6% | 1,250 | -11.3% | 0.00% | -50.0% |
| Q3 2013 | $117,000 | – | 1,410 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,417,548 | $255,675,000 | 13.66% |
| HWG Holdings LP | 339,799 | $13,538,000 | 8.73% |
| DOWLING & YAHNKE LLC | 675,798 | $26,924,000 | 3.78% |
| GARRISON BRADFORD & ASSOCIATES INC | 99,300 | $3,956,000 | 3.74% |
| WILLIAM HARRIS INVESTORS INC | 283,834 | $11,308,000 | 3.35% |
| SECTORAL ASSET MANAGEMENT INC | 1,222,401 | $48,700,000 | 2.10% |
| AVALON CAPITAL MANAGEMENT | 49,999 | $1,992,000 | 1.68% |
| PINNACLE ASSOCIATES LTD | 2,016,369 | $80,332,000 | 1.57% |
| PERKINS CAPITAL MANAGEMENT INC | 48,515 | $1,933,000 | 1.30% |
| NCM Capital Advisers, Inc. | 31,100 | $1,239,000 | 1.28% |